What if instead of temporarily relieving your allergies with medication, you could train your immune system to stop overreacting to your allergens altogether? That’s the idea behind allergy ...

Allergen immunotherapy (AIT) encompasses medical interventions designed to induce long-term tolerance to specific allergens by administering gradually increasing doses of the offending substance.

Please provide your email address to receive an email when new articles are posted on . Allergen immunotherapy prevented the onset of asthma for those with house dust mite allergy. The therapy also ...

Subcutaneous immunotherapy (SCIT) is a unique therapy for allergic disease because it provides symptomatic relief while modifying the allergic disease by targeting the underlying immunological ...

Two new studies being presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Orlando shine a spotlight on oral immunotherapy and oral food challenges ...

Allergen-specific immunotherapy (AIT) is the only disease-modifying treatment for IgE-mediated allergic disorders and aims to restore immune tolerance to otherwise harmless environmental or food ...

Hailed for opening a new chapter in food allergy management, oral immunotherapy (OIT) is nevertheless going through growing pains in accessibility and acceptance in clinical practice. In 2020, the FDA ...

AIT significantly reduces AR and asthma medication use, including oral corticosteroids and antibiotics, over a 9-year period in children and adolescents. The study shows improved asthma control and a ...

From infections and allergies to brain diseases and autoimmune disorders, a wave of trials offers hope ...

The Stallergenes Greer Foundation, dedicated to advancing allergy research, fostering innovation and addressing environmental ...

The use of allergen immunotherapy (AIT) for allergic respiratory diseases in HIV-infected patients is undergoing investigation. Data from pilot studies and case reports suggest that AIT may be safe ...

Frost & Sullivan has released the "2026 Global Allergen Specific Immunotherapy Development Blue Book", a comprehensive ...